Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women

Journal of General Virology

Volumn 86, Issue 10, 2005, Pages 2709-2720

  Schlecht, Nicolas F ^a   Burk, Robert D ^a   Palefsky, Joel M ^b   Minkoff, Howard ^c   Xue, Xiaonan ^a   Massad, L Stewart ^d   Bacon, Melanie ^e   Levine, Alexandra M ^f   Anastos, Kathryn ^a   Gange, Stephen J ^g   Watts, D Heather ^h   Da Costa, Maria M ^b   Chen, Zigui ^a   Bang, Ji Yon ^a   Fazzari, Melissa ^a   Hall, Charles ^a   Strickler, Howard D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MAIMONIDES MEDICAL CENTER   (United States)

^d SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^h EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS RNA;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; CARCINOGENICITY; CAUCASIAN; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IMMUNOGENICITY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; NONHUMAN; PAPANICOLAOU TEST; PERSISTENT VIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STRAIN DIFFERENCE; T LYMPHOCYTE; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS LOAD; VIRUS VIRULENCE;

ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; COHORT STUDIES; DNA, VIRAL; FEMALE; HIV; HIV SEROPOSITIVITY; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; VARIATION (GENETICS);

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRUS;

EID: 26244454162     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.81060-0     Document Type: Article

References (53)

1. Ahdieh, L., Klein, R. S., Burk, R. & 7 other authors (2001). Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis 184, 682-690.
2. Barkan, S. E., Melnick, S. L., Preston-Martin, S. & 7 other authors (1998). The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology 9, 117-125.
3. Bernard, H. U., Chan, S. Y., Manos, M. M., Ong, C. K., Villa, L. L., Delius, H., Peyton, C. L., Bauer, H. M. & Wheeler, C. M. (1994). Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 170, 1077-1085.
4. Berumen, J., Ordonez, R. M., Lazcano, E. & 7 other authors (2001). Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst 93, 1325-1330.
5. Bontkes, H. J., van Duin, M., de Gruijl, T. D. & 11 other authors (1998). HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants. Int J Cancer 78, 166-171.
6. Bosch, F. X., Manos, M. M., Munoz, N. & 7 other authors (1995). Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87, 796-802.
7. Burk, R. D., Terai, M., Gravitt, P. E. & 10 other authors (2003). Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res 63, 7215-7220.
8. Casas, L., Galvan, S. C., Ordonez, R. M., Lopez, N., Guido, M. & Berumen, J. (1999). Asian-american variants of human papilloma-virus type 16 have extensive mutations in the E2 gene and are highly amplified in cervical carcinomas. Int J Cancer 83, 449-455.
9. Chaturvedi, A. K., Brinkman, J. A., Gaffga, A. M., Dumestre, J., Clark, R. A., Braly, P. S., Dunlap, K., Kissinger, P. J. & Hagensee, M. E. (2004). Distribution of human papillomavirus type 16 variants in human immunodeficiency virus type 1-positive and -negative women. J Gen Virol 85, 1237-1241.
10. Da Costa, M. M., Hogeboom, C. J., Holly, E. A. & Palefsky, J. M. (2002). Increased risk of high-grade anal neoplasia associated with a human papillomavirus type 16 E6 sequence variant. J Infect Dis 185, 1229-1237.
11. de Boer, M. A., Peters, L. A., Aziz, M. F., Siregar, B., Cornain, S., Vrede, M. A., Jordanova, E. S., Kolkman-Uljee, S. & Fleuren, G. J. (2004). Human papillomavirus type 16 E6, E7, and L1 variants in cervical cancer in Indonesia, Suriname, and The Netherlands. Gynecol Oncol 94, 488-494.
12. de Boer, M. A., Peters, L. A., Aziz, M. F., Siregar, B., Cornain, S., Vrede, M. A., Jordanova, E. S. & Fleuren, G. J. (2005). Human papillomavirus type 18 variants: histopathology and E6/E7 polymorphisms in three countries. Int J Cancer 114, 422-425.
13. del Refugio Gonzalez-Losa, M., Laviada Mier y Teran, M. A., Puerto-Solis, M. & Garcia-Carranca, A. (2004). Molecular variants of HPV type 16 E6 among Mexican women with LSIL and invasive cancer. J Clin Virol 29, 95-98.
14. Franco, E. L., Villa, L. L., Sobrinho, J. P., Prado, J. M., Rousseau, M. C., Desy, M. & Rohan, T. E. (1999). Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 180, 1415-1423.
15. Gemignani, F., Landi, S., Chabrier, A., Smet, A., Zehbe, I., Canzian, F. & Tommasino, M. (2004). Generation of a DNA microarray for determination of E6 natural variants of human papillomavirus type 16. J Virol Methods 119, 95-102.
16. Giannoudis, A. & Herrington, C. S. (2001). Human papilloma-virus variants and squamous neoplasia of the cervix. J Pathol 193, 295-302.
17. Giuliano, A. R., Harris, R., Sedjo, R. L. & 7 other authors (2002). Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study. J Infect Dis 186, 462-469.
18. Hecht, J. L., Kadish, A. S., Jiang, G. & Burk, R. D. (1995). Genetic characterization of the human papillomavirus (HPV) 18 E2 gene in clinical specimens suggests the presence of a subtype with decreased oncogenic potential. Int J Cancer 60, 369-376.
19. Hildesheim, A., Schiffman, M., Bromley, C. & 12 other authors (2001). Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst 93, 315-318.
20. Ho, L., Chan, S. Y., Burk, R. D. & 7 other authors (1993). The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol 67, 6413-6423.
21. Ho, G. Y., Bierman, R., Beardsley, L., Chang, C. J. & Burk, R. D. (1998). Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338, 423-428.
22. Hu, X., Pang, T., Guo, Z., Mazurenko, N., Kisseljov, F., Ponten, J. & Nister, M. (2001a). HPV16 E6 gene variations in invasive cervical squamous cell carcinoma and cancer in situ from Russian patients. Br J Cancer 84, 791-795.
23. Hu, X., Pang, T., Guo, Z., Ponten, J., Nister, M. & Bernard Afink, G. (2001b). Oncogene lineages of human papillomavirus type 16 E6, E7 and E5 in preinvasive and invasive cervical squamous cell carcinoma. J Pathol 195, 307-311.
24. Icenogle, J. P., Laga, M., Miller, D., Manoka, A. T., Tucker, R. A. & Reeves, W. C. (1992). Genotypes and sequence variants of human papillomavirus DNAs from human immunodeficiency virus type 1-infected women with cervical intraepithelial neoplasia. J Infect Dis 166, 1210-1216.
25. Kammer, C., Tommasino, M., Syrjanen, S., Delius, H., Hebling, U., Warthorst, U., Pfister, H. & Zehbe, I. (2002). Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease. Br J Cancer 86, 269-273.
26. Liaw, K. L., Hildesheim, A., Burk, R. D. & 9 other authors (2001). A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis 183, 8-15.
27. Lizano, M., Berumen, J., Guido, M. C., Casas, L. & Garcia-Carranca, A. (1997). Association between human papillomavirus type 18 variants and histopathology of cervical cancer. J Natl Cancer Inst 89, 1227-1231.
28. Londesborough, P., Ho, L., Terry, G., Cuzick, J., Wheeler, C. & Singer, A. (1996). Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer 69, 364-368.
29. Matsumoto, K., Yoshikawa, H., Nakagawa, S. & 8 other authors (2000). Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population. Cancer Lett 156, 159-165.
30. Mayrand, M. H., Coutlee, F., Hankins, C., Lapointe, N., Forest, P., de Ladurantaye, M. & Roger, M. (2000). Detection of human papillomavirus type 16 DNA in consecutive genital samples does not always represent persistent infection as determined by molecular variant analysis. J Clin Microbiol 38, 3388-3393.
31. Moscicki, A. B., Ellenberg, J. H., Farhat, S. & Xu, J. (2004). Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type. J Infect Dis 190, 37-45.
32. Nindl, I., Rindfleisch, K., Lotz, B., Schneider, A. & Durst, M. (1999). Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer. Int J Cancer 82, 203-207.
33. Ong, C. K., Chan, S. Y., Campo, M. S. & 7 other authors (1993). Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol 67, 6424-6431.
34. Palefsky, J. M., Minkoff, H., Kalish, L. A. & 7 other authors (1999). Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 91, 226-236.
35. Perez-Gallego, L., Moreno-Bueno, G., Sarrio, D., Suarez, A., Gamallo, C. & Palacios, J. (2001). Human papillomavirus-16 E6 variants in cervical squamous intraepithelial lesions from HIV-negative and HIV-positive women. Am J Clin Pathol 116, 143-148.
36. Picconi, M. A., Alonio, L. V., Sichero, L., Mbayed, V., Villa, L. L., Gronda, J., Campos, R. & Teyssie, A. (2003). Human papillomavirus type-16 variants in Quechua aboriginals from Argentina. J Med Virol 69, 546-552.
37. Richardson, H., Kelsall, G., Tellier, P., Voyer, H., Abrahamowicz, M., Ferenczy, A., Coutlee, F. & Franco, E. L. (2003). The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev 12, 485-490.
38. Rousseau, M. C., Pereira, J. S., Prado, J. C., Villa, L. L., Rohan, T. E. & Franco, E. L. (2001). Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection. J Infect Dis 184, 1508-1517.
39. Strickler, H. D., Palefsky, J. M., Shah, K. V. & 16 other authors (2003). Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst 95, 1062-1071.
40. Terry, G., Ho, L. & Cuzick, J. (1997). Analysis of E2 amino acid variants of human papillomavirus types 16 and 18 and their associations with lesion grade and HLA DR/DQ type. Int J Cancer 73, 651-655.
41. van Duin, M., Snijders, P. J., Vossen, M. T., Klaassen, E., Voorhorst, F., Verheijen, R. H., Helmerhorst, T. J., Meijer, C. J. & Walboomers, J. M. (2000). Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis. J Gen Virol 81, 317-325.
42. Villa, L. L., Sichero, L., Rahal, P., Caballero, O., Ferenczy, A., Rohan, T. & Franco, E. L. (2000). Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 81, 2959-2968.
43. Walboomers, J. M., Jacobs, M. V., Manos, M. M. & 7 other authors (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189, 12-19.
44. Wheeler, C. M., Yamada, T., Hildesheim, A. & Jenison, S. A. (1997). Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization. J Clin Microbiol 35, 11-19.
45. Xi, L. F., Demers, G. W., Koutsky, L. A., Kiviat, N. B., Kuypers, J., Watts, D. H., Holmes, K. K. & Galloway, D. A. (1995). Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection. J Infect Dis 172, 747-755.
46. Xi, L. F., Koutsky, L. A., Galloway, D. A., Kuypers, J., Hughes, J. P., Wheeler, C. M., Holmes, K. K., & Kiviat, N. B. (1997). Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 89, 796-802.
47. Xi, L. F., Critchlow, C. W., Wheeler, C. M. & 9 other authors (1998). Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variants. Cancer Res 58, 3839-3844.
48. Xi, L. F., Carter, J. J., Galloway, D. A., Kuypers, J., Hughes, J. P., Lee, S. K., Adam, D. E., Kiviat, N. B. & Koutsky, L. A. (2002). Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university students. Cancer Epidemiol Biomarkers Prev 11, 343-351.
49. Yamada, T., Wheeler, C. M., Halpern, A. L., Stewart, A. C., Hildesheim, A. & Jenison, S. A. (1995). Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol 69, 7743-7753.
50. Yamada, T., Manos, M. M., Peto, J., Greer, C. E., Munoz, N., Bosch, F. X. & Wheeler, C. M. (1997). Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 71, 2463-2472.
51. Zehbe, I., Wilander, E., Delius, H. & Tommasino, M. (1998). Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 58, 829-833.
52. Zehbe, I., Tachezy, R., Mytilineos, J. & 7 other authors (2001a). Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int J Cancer 94, 711-716.
53. Zehbe, I., Voglino, G., Wilander, E., Delius, H., Marongiu, A., Edler, L., Klimek, F., Andersson, S. & Tommasino, M. (2001b). p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development. Cancer Res 61, 608-611.